Ocular Therapeutix, INC
SEC CIK 1393434 · OCUL · last insider filing 2026-06-18
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Dugel Pravin | Director · See Remarks | filed 2024 - 2026 |
| Raines Merilee | Director | filed 2021 - 2026 |
| Lindstrom Richard L MD | Director | filed 2014 - 2026 |
| Graves Adrienne L | Director | filed 2023 - 2026 |
| Warden Charles M | Director | filed 2014 - 2026 |
| Williams Leslie J. | Director | filed 2019 - 2026 |
| Hong Seung Suh | Director | filed 2019 - 2026 |
| Heier Jeffrey S. | Director · Chief Scientific Officer | filed 2015 - 2026 |
| Mattessich Antony C. | Director · President and CEO | filed 2017 - 2024 |
| Peacock Bruce | Director | filed 2014 - 2021 |
| Sawhney Amarpreet | Director · President and CEO | filed 2014 - 2019 |
| Oshea William J | Director | filed 2015 - 2018 |
| Chadha Jaswinder | Director | filed 2014 - 2018 |
| Garvey James M | Director | filed 2014 - 2017 |
| Crane Alan L | Director | filed 2014 - 2014 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Robins Jason Shand | Interim CFO | filed 2026 - 2026 |
| Waheed Nadia | Chief Medical Officer | filed 2024 - 2026 |
| Kaiser Peter | Chief Development Officer | filed 2024 - 2026 |
| Nayak Sanjay | Chief Strategy Officer | filed 2024 - 2026 |
| Notman Donald | See Remarks | filed 2017 - 2026 |
| Robinson David Wayne | Global CCO | filed 2026 - 2026 |
| Anderman Todd | Chief Legal Officer | filed 2024 - 2026 |
| Saroj Namrata | Chief Business Officer | filed 2025 - 2026 |
| Meyers Steve Lawrence | Chief Commercial Officer | filed 2025 - 2026 |
| White Christopher G | Chief Business Officer | filed 2021 - 2024 |
| Ozden Rabia Gurses | Chief Medical Officer | filed 2022 - 2024 |
| Strassburger Philip C. | General Counsel | filed 2020 - 2024 |
| Goldstein Michael H. | President, Ophthalmology & CMO | filed 2017 - 2022 |
| Kitchen Patricia | Chief Operations Officer | filed 2019 - 2021 |
| Bollag Daniel M | Sr. VP Reg. Affairs & Quality | filed 2017 - 2019 |
| Hanley Kevin F. | Sr. VP Technical Operations | filed 2018 - 2019 |
| Migausky George V | Interim CFO | filed 2017 - 2017 |
| Smith W Bradford | See Remarks | filed 2014 - 2017 |
| Fortune James | Chief Operating Officer | filed 2014 - 2017 |
| Ankerud Eric | See Remarks | filed 2014 - 2017 |
| Talamo Jonathan H. | Chief Medical Officer | filed 2016 - 2017 |
| Hurley Charles Andrew | Chief Commercial Officer | filed 2016 - 2017 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.